The in vivo animal results and protein analysis in tumor indicated that the combination of DOX and EGCG showed the best anti-tumor effect and the strongest protein regulation in p53, p-NF-κB, and p-MDM2, among three treatment groups of DOX, EGCG, and DOX+EGCG. This evidence concerns the gene TP53 and neoplasm.